Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0ZXPKZ)
| ADC Name |
ZA202500415A-ADC Example 7
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
ZA202500415A-ADC Example 7
Click to Show/Hide
|
|||||
| Organization |
MYRICX PHARMA LIMITED | IMPERIAL COLLEGE INNOVATIONS LIMITED
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
5
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
NMT inhibitor 1
|
Payload Info | ||||
| Payload Target |
N-Myristoyltransferase (NMT)
|
Target Info | ||||
| Linker Name |
Mc-Gly-Gly-Phe-Gly
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||